Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
42.40    0.00 (0.00%)
Bid:
41.40
Ask:
43.40
Spread: 2.00 (4.831%)
Market Cap: £66.18m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Circ re. Enhanced Buyback Scheme

21 Sep 2012 14:17

RNS Number : 8878M
Maven Income and Growth VCT 3 PLC
21 September 2012
 

MAVEN INCOME & GROWTH VCT 3 PLC

PUBLICATION OF CIRCULAR

Summary

The board of directors ("Board") of Maven Income & Growth VCT 3 plc ("the Company") is today sending out a circular ("Circular") to shareholders in relation to the proposed enhanced buyback scheme in respect of the ordinary shares of 10p each in thecapital of the Company ("Shares"), such scheme being for up to 14.99% of the issued share capital of the Company ("Enhanced Buyback Scheme").

 

The Enhanced Buyback Scheme is subject to shareholder approval being provided at a general meeting convened for 16 October 2012pursuant to the Circular. The Enhanced Buyback Scheme has opened today for application.

Enhanced Buyback Scheme

The Company is offering to purchase up to a maximum of 4,708,596 existing Shares, which represent 14.99% of the issued share capital as at 21 September 2012, subject to the proceeds of sale being reinvested in new Shares.

The record date to be eligible to participate in the Enhanced Buyback Scheme is 5.00 p.m. on 21 September 2012.

The closing date for applications pursuant to the Enhanced Buyback Scheme is 12.00 noon on 29 October 2012.

If the Enhanced Buyback Scheme is over subscribed, applications will be scaled back and accepted as follows:

Firstly, valid applications from all shareholders eligible to participate would be accepted to the extent that the number of Existing Shares to be purchased represent 14.99% or less of their holding of Existing Shares on 21September 2012 (rounded down to the nearest whole number of Existing Shares) and secondly, valid applications thereafter would be accepted pro rata to the number of Existing Shares tendered, subject always to the Board's discretion.

Further details on the Enhanced Buyback Scheme, including the terms and conditions and tax consequences of participating, are set out in the Circular and application form. Shareholders are further advised to consult their independent financial adviser.

Availability of Documents

The Circular has been submitted to the Financial Services Authority and will shortly be available for inspection both at the National Storage Mechanism, which is located at:

 

http://www.hemscott.com/nsm.do

 

and the Company's website:

 

http://www.mavencp.com/migvct3

 

Rosemary O'Neil

Maven Capital Partners UK LLP

0141 306 7400

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CIRUAAORUNAKUAR
Date   Source Headline
27th Mar 20251:11 pmRNSDirector/PDMR Shareholding
27th Mar 20251:06 pmRNSIssue of Equity
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
24th Mar 20253:53 pmRNSUnaudited Net Asset Value
18th Mar 20253:37 pmRNSAnnual Financial Report
28th Feb 20254:32 pmRNSTransaction in Own Shares
27th Feb 20251:54 pmRNSUnaudited NAV and Proposed Final Dividend
19th Feb 202510:17 amRNSDirector/PDMR Shareholding
19th Feb 202510:14 amRNSDirector/PDMR Shareholding
19th Feb 202510:06 amRNSIssue of Equity
28th Jan 202512:15 pmRNSStatement re Offer for Subscription
18th Dec 20249:35 amRNSIssue of Equity
13th Dec 20242:42 pmRNSNet Asset Value(s)
14th Nov 20242:55 pmRNSResult of General Meeting
25th Oct 20243:49 pmRNSTransaction in Own Shares
27th Sep 20244:31 pmRNSPublication of a Prospectus
6th Sep 202410:25 amRNSDirector/PDMR Shareholding
6th Sep 202410:01 amRNSIssue of Equity
5th Sep 20242:26 pmRNSStatement re Dividend Investment Scheme
5th Sep 20241:40 pmRNSUnaudited Net Asset Value
18th Jul 20245:27 pmRNSHalf-year Report
10th Jul 20245:08 pmRNSTransaction in Own Shares
8th Jul 20244:07 pmRNSStatement re NAV and Interim Dividend
18th Jun 202411:53 amRNSStatement re Intended Offers for Subscription
10th May 20244:11 pmRNSTransaction in Own Shares
3rd May 20249:35 amRNSDirector/PDMR Shareholding
3rd May 20249:33 amRNSIssue of Equity
2nd May 20241:31 pmRNSResult of AGM
1st May 202410:06 amRNSDirector/PDMR Shareholding
1st May 202410:03 amRNSIssue of Equity
26th Apr 20242:40 pmRNSNet Asset Value - Dividend Investment Scheme
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:37 pmRNSIssue of Equity
28th Mar 202410:16 amRNSStatement re Offer for Subscription
27th Mar 202410:36 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:46 pmRNSUnaudited Net Asset Value
15th Mar 20245:18 pmRNSAnnual Financial Report
21st Feb 20244:24 pmRNSTransaction in Own Shares
8th Feb 202410:30 amRNSDirector/PDMR Shareholding
8th Feb 202410:28 amRNSDirector/PDMR Shareholding
8th Feb 202410:15 amRNSIssue of Equity
6th Feb 202411:07 amRNSDividend Declaration
19th Dec 20233:25 pmRNSIssue of Equity
18th Dec 20235:17 pmRNSUnaudited Net Asset Value
5th Dec 202311:42 amRNSDirectorate Change
9th Nov 20233:47 pmRNSResult of General Meeting
8th Nov 20234:01 pmRNSTransaction in Own Shares
7th Nov 20234:47 pmRNSTransaction in Own Shares
19th Oct 20234:15 pmRNSNet Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.